Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · IEX Real-Time Price · USD
132.00
-0.54 (-0.41%)
At close: Apr 19, 2024, 4:00 PM
132.50
+0.50 (0.38%)
After-hours: Apr 19, 2024, 5:10 PM EDT

Neurocrine Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
1,8871,4891,1341,046788.1451.2161.631519.770
Upgrade
Revenue Growth (YoY)
26.76%31.34%8.38%32.71%74.67%179.16%977.51%-24.12%--
Upgrade
Cost of Revenue
39.723.214.310.17.44.91.25000
Upgrade
Gross Profit
1,8471,4661,1191,036780.7446.3160.371519.770
Upgrade
Selling, General & Admin
887.6752.7583.3433.3354.1248.9169.9168.0832.4817.99
Upgrade
Research & Development
565463.8328.1275200155.891.8394.2981.4946.43
Upgrade
Other Operating Expenses
143.90105.3164.5154.34.830000
Upgrade
Operating Expenses
1,5971,2171,017872.8708.4409.5291.73162.37113.9764.41
Upgrade
Operating Income
250.9249102.516372.336.8-131.36-147.37-94.2-64.41
Upgrade
Interest Expense / Income
4.67.125.832.83230.519.52000
Upgrade
Other Expense / Income
-85.828-24.723.5-6.2-15.5-8.34-6.28-5.27-3.87
Upgrade
Pretax Income
332.1213.9101.4106.746.521.8-142.54-141.09-88.93-60.54
Upgrade
Income Tax
82.459.411.8-300.69.50.70000
Upgrade
Net Income
249.7154.589.6407.33721.1-142.54-141.09-88.93-60.54
Upgrade
Net Income Growth
61.62%72.43%-78.00%1000.81%75.36%-----
Upgrade
Shares Outstanding (Basic)
98969593929088878475
Upgrade
Shares Outstanding (Diluted)
101999898969588878475
Upgrade
Shares Change
2.12%1.02%0.10%2.19%0.31%8.30%1.59%2.62%13.30%11.33%
Upgrade
EPS (Basic)
2.561.610.954.380.400.23-1.62-1.63-1.05-0.81
Upgrade
EPS (Diluted)
2.471.560.924.160.390.22-1.62-1.63-1.05-0.81
Upgrade
EPS Growth
58.33%69.57%-77.88%966.67%77.27%-----
Upgrade
Free Cash Flow
361.6322.9233.1217.6132.376.6-101.26-110.28-39.92-48.71
Upgrade
Free Cash Flow Per Share
3.703.372.462.341.440.85-1.15-1.27-0.47-0.65
Upgrade
Gross Margin
97.90%98.44%98.74%99.03%99.06%98.91%99.22%100.00%100.00%-
Upgrade
Operating Margin
13.30%16.73%9.04%15.58%9.17%8.16%-81.27%-982.48%-476.51%-
Upgrade
Profit Margin
13.23%10.38%7.90%38.94%4.69%4.68%-88.19%-940.60%-449.84%-
Upgrade
Free Cash Flow Margin
19.16%21.69%20.56%20.81%16.79%16.98%-62.65%-735.17%-201.94%-
Upgrade
Effective Tax Rate
24.81%27.77%11.64%-281.72%20.43%3.21%----
Upgrade
EBITDA
358236.6138.1148.185.956.3-120.62-139.64-87.92-59.72
Upgrade
EBITDA Margin
18.97%15.89%12.18%14.16%10.90%12.48%-74.63%-930.91%-444.74%-
Upgrade
Depreciation & Amortization
21.315.610.98.67.442.41.451.010.83
Upgrade
EBIT
336.7221127.2139.578.552.3-123.02-141.09-88.93-60.54
Upgrade
EBIT Margin
17.84%14.85%11.22%13.34%9.96%11.59%-76.11%-940.60%-449.84%-
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).